Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENDO INTERNATIONAL PLC

(ENDP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Endo International plc
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.

Number of employees : 3 397 people.
Sales per Business
20192020Delta
Sterile Injectables1 063.1336.5%1 238.8542.7% +16.53%
Generic Pharmaceuticals879.8830.2%783.1127% -11%
Branded Pharmaceuticals855.4029.4%781.7826.9% -8.61%
International Pharmaceuticals115.954%99.343.4% -14.33%
USD in Million
Sales per region
20192020Delta
United States2 798.4296%2 803.7496.6% +0.19%
International115.954%99.343.4% -14.33%
USD in Million
Managers
Name Title Age Since
Blaise A Coleman President, Chief Executive Officer & Director 46 2020
Mark Bradley Chief Financial Officer & Executive Vice President 50 2020
Ruth Thorpe Chief Information Officer - 2017
Robert Polke Global Head-Operations - 2020
Susan Williamson Chief Compliance Officer & Senior Vice President - 2018
Nancy J. Hutson, Dr. Independent Director 70 2014
William Patrick Montague Independent Director 73 2014
Shane M. Cooke Independent Non-Executive Director 57 2014
Michael Hyatt Independent Director 74 2014
Mark Barberio Chairman 57 2021
Members of the board
Name Title Age Since
Mark Barberio Chairman 57 2021
Nancy J. Hutson, Dr. Independent Director 70 2014
William Patrick Montague Independent Director 73 2014
Shane M. Cooke Independent Non-Executive Director 57 2014
Michael Hyatt Independent Director 74 2014
Blaise A Coleman President, Chief Executive Officer & Director 46 2020
Mary Christine Smith, Dr. Independent Non-Executive Director - 2020
Jennifer M. Chao Independent Director 50 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 233,305,326 229,713,754 98.5% 0 0.0% 98.5%
Shareholders
NameEquities%
The Vanguard Group, Inc. 25,067,845 10.7%
TPG Group Holdings (SBS) Advisors, Inc. 22,152,136 9.49%
Paulson & Co., Inc. 18,327,012 7.86%
Renaissance Technologies LLC 17,588,661 7.54%
Capital Research & Management Co. 12,300,000 5.27%
Contrarius Investment Management Ltd. 10,943,757 4.69%
SSgA Funds Management, Inc. 7,937,228 3.40%
Fidelity Management & Research Co. LLC 7,545,000 3.23%
BlackRock Fund Advisors 7,056,209 3.02%
OrbiMed Advisors Private Equity 6,165,464 2.64%
Company contact information
Endo International Plc
Minerva House
Simmonscourt Road
1st Floor, Ballsbridge
Dublin 4

Phone : +353.1.268.2000
Web : http://www.endo.com